Patient perception of dyskinesia in Parkinson's disease

被引:42
|
作者
Hung, S. W. [2 ,3 ]
Adeli, G. M. [2 ]
Arenovich, T. [4 ]
Fox, S. H. [2 ]
Lang, A. E. [1 ,2 ]
机构
[1] Univ Toronto, Movement Disorders Ctr, Div Neurol, Toronto, ON M5T 2S8, Canada
[2] Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada
[3] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA
[4] Ctr Addict & Mental Hlth, Dept Clin Res, Toronto, ON, Canada
来源
关键词
QUALITY-OF-LIFE; LEVODOPA; ROPINIROLE; TRIAL; PRAMIPEXOLE; PREVALENCE; 5-YEAR;
D O I
10.1136/jnnp.2009.173286
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.
引用
下载
收藏
页码:1112 / 1115
页数:4
相关论文
共 50 条
  • [31] Memantine and reduced time with dyskinesia in Parkinson's Disease
    Wictorin, K.
    Widner, H.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (05): : 355 - 360
  • [32] Online monitoring of dyskinesia in patients with Parkinson's disease
    Keijsers, NLW
    Horstink, MWIM
    Gielen, SCAM
    IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, 2003, 22 (03): : 96 - 103
  • [33] Classifying risk factors for dyskinesia in Parkinson's disease
    Sharma, J. C.
    Bachmann, C. G.
    Linazasoro, G.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (08) : 490 - 497
  • [34] PREDICTING THE RISK OF DYSKINESIA DEVELOPMENT IN PARKINSON'S DISEASE
    Adiguzel, Ahmet
    Ozturk, Unal
    Altinayar, Sibel
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2020, 23 (02): : 224 - 229
  • [35] Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia
    Vegas-Suarez, Sergio
    Paredes-Rodriguez, Elena
    Aristieta, Asier
    Lafuente, Jose V.
    Miguelez, Cristina
    Ugedo, Luisa
    NEW THERAPEUTIC STRATEGIES FOR BRAIN EDEMA AND CELL INJURY, 2019, 146 : 259 - 279
  • [36] Recurrence of dyskinesia as a side-effect of mirabegron in a patient with Parkinson's disease on DBS (GPi)
    Murchison, Andrew G.
    Fletcher, Claire
    Cheeran, Binith
    PARKINSONISM & RELATED DISORDERS, 2016, 27 : 107 - 108
  • [37] Levodopa, motor fluctuations and dyskinesia in Parkinson's disease
    Mueller, Thomas
    Russ, Hermann
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (13) : 1715 - 1730
  • [38] Parkinson's disease related dyskinesia in a Tanzanian population
    Dotchin, Catherine L.
    Gray, William K.
    Dewhurst, Felicity
    Massawe, John
    Chaote, Paul
    Walker, Richard W.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (09) : 1109 - 1110
  • [39] Automated Assessment of Bradykinesia and Dyskinesia in Parkinson's Disease
    Griffiths, Robert I.
    Kotschet, Katya
    Arfon, Sian
    Xu, Zheng Ming
    Johnson, William
    Drago, John
    Evans, Andrew
    Kempster, Peter
    Raghav, Sanjay
    Horne, Malcolm K.
    JOURNAL OF PARKINSONS DISEASE, 2012, 2 (01) : 47 - 55